Racial Disparity in Barrett's Esophagus

巴雷特食管的种族差异

基本信息

  • 批准号:
    8068482
  • 负责人:
  • 金额:
    $ 35.81万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-09-01 至 2013-08-31
  • 项目状态:
    已结题

项目摘要

Barrett's esophagus (BE), a prelimalignant disease predisposing to human esophageal adenocarcinoma (EAC), is known to predominantly afflict Caucasian Americans. Our preliminary data have shown that in human BE a series of genes and pathways are activated to mediate the process of intestinal metaplasia, and thatintestinal transcription factors (e.g., Cdxl and Cdx2) are crucial to this process. Both Cdxl and Cdx2 are induced and expressed in esophageal epithelial cells through loss ef promoter methylation. Transfection of Cdx2 into human esophageal squamous epithelial cells induces metaplastic changes in morphology and gene expression, in this proposal, we hypothesize that environmental factors, genetic factors, and potentially gene-environment interactions play crucial roles in the observed racial disparity in BE. Clinical data, gastric secretions, endoscopic biopsy samples and blood samples will be collected from Caucasian and African American patients to identify critical environmental and genetic factors leading to BE. We hypothesize that differential distribution of genetic risk factors make Caucasian Americans more susceptible to BE than African Americans. Understanding the pathogenesis of the lesion is vital to future attempts at preventing metaplastic and dysplastic changes in the esophagus.
巴雷特食管(BE)是一种易致人类食管腺癌(EAC)的癌前病变,已知主要发生在美国白种人身上。我们的初步数据表明,在人BE中,一系列基因和途径被激活来介导肠化生过程,肠道转录因子(如Cdxl和Cdx2)在这一过程中起着至关重要的作用。Cdxl和Cdx2都是通过丢失启动子甲基化在食管上皮细胞中诱导和表达的。将Cdx2转染人食管鳞状上皮细胞可引起形态学和基因表达的化生变化,在本研究中,我们假设环境因素、遗传因素以及潜在的基因-环境相互作用在BE中观察到的种族差异中起关键作用。临床资料,胃分泌物,内窥镜

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

XIAOXIN Luke CHEN其他文献

XIAOXIN Luke CHEN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('XIAOXIN Luke CHEN', 18)}}的其他基金

NRF2-ACSS2 Axis in Alcohol-induced Metabolic Reprogramming and Esophageal Pathology
NRF2-ACSS2 轴在酒精诱导的代谢重编程和食管病理学中的作用
  • 批准号:
    10810414
  • 财政年份:
    2022
  • 资助金额:
    $ 35.81万
  • 项目类别:
NRF2-ACSS2 Axis in Alcohol-induced Metabolic Reprogramming and Esophageal Pathology
NRF2-ACSS2 轴在酒精诱导的代谢重编程和食管病理学中的作用
  • 批准号:
    10673201
  • 财政年份:
    2022
  • 资助金额:
    $ 35.81万
  • 项目类别:
Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma
NRF2高食管鳞癌的机制及靶向治疗
  • 批准号:
    10407469
  • 财政年份:
    2020
  • 资助金额:
    $ 35.81万
  • 项目类别:
Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma
NRF2高食管鳞癌的机制及靶向治疗
  • 批准号:
    10530998
  • 财政年份:
    2020
  • 资助金额:
    $ 35.81万
  • 项目类别:
Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma
NRF2高食管鳞癌的机制及靶向治疗
  • 批准号:
    10851493
  • 财政年份:
    2020
  • 资助金额:
    $ 35.81万
  • 项目类别:
Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma
NRF2高食管鳞癌的机制及靶向治疗
  • 批准号:
    10850620
  • 财政年份:
    2020
  • 资助金额:
    $ 35.81万
  • 项目类别:
NOTCH-PAX9 signaling in alcohol-induced esophageal injury
NOTCH-PAX9 信号在酒精性食管损伤中的作用
  • 批准号:
    10023247
  • 财政年份:
    2019
  • 资助金额:
    $ 35.81万
  • 项目类别:
Research Infrastructure Core (RIC)
研究基础设施核心 (RIC)
  • 批准号:
    9977710
  • 财政年份:
    2017
  • 资助金额:
    $ 35.81万
  • 项目类别:
Research Infrastructure Core (RIC)
研究基础设施核心 (RIC)
  • 批准号:
    10204733
  • 财政年份:
    2017
  • 资助金额:
    $ 35.81万
  • 项目类别:
Pilot Project 2: Nrf2 Activation in Esophageal Squamous Cell Carcinogenesis In Vivo
试点项目 2:Nrf2 激活在食管鳞状细胞体内癌变过程中的作用
  • 批准号:
    9050352
  • 财政年份:
    2010
  • 资助金额:
    $ 35.81万
  • 项目类别:

相似国自然基金

大肠癌发生机制的adenoma-adenocarcinoma pathway同serrated pathway的关系的研究
  • 批准号:
    30840003
  • 批准年份:
    2008
  • 资助金额:
    12.0 万元
  • 项目类别:
    专项基金项目

相似海外基金

Synergistic Radiosensitization of Hypoxic Pancreatic Adenocarcinoma using Gd-Texaphyrin Oxygen-Loaded Nanodroplets
使用 Gd-Texaphyrin 载氧纳米液滴对缺氧胰腺腺癌进行协同放射增敏
  • 批准号:
    478914
  • 财政年份:
    2023
  • 资助金额:
    $ 35.81万
  • 项目类别:
    Operating Grants
Expression mechanism of immune checkpoint molecules after carbon-ion radiotherapy in cervical adenocarcinoma specimens
宫颈腺癌碳离子放疗后免疫检查点分子的表达机制
  • 批准号:
    23K14913
  • 财政年份:
    2023
  • 资助金额:
    $ 35.81万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Study of fibrosis in pancreatic ductal adenocarcinoma (PDAC) and application of adipose-derived stromal/stem cells for PDAC treatment
胰腺导管腺癌(PDAC)纤维化的研究以及脂肪源性基质/干细胞在 PDAC 治疗中的应用
  • 批准号:
    23K15035
  • 财政年份:
    2023
  • 资助金额:
    $ 35.81万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Therapeutic Targeting of NSD2 in Lung Adenocarcinoma
NSD2 在肺腺癌中的治疗靶向
  • 批准号:
    10657069
  • 财政年份:
    2023
  • 资助金额:
    $ 35.81万
  • 项目类别:
IRAK4 AS A NOVEL IMMUNOTHERAPEUTIC TARGET IN PANCREATIC DUCTAL ADENOCARCINOMA
IRAK4 作为胰腺导管腺癌的新型免疫治疗靶点
  • 批准号:
    10442874
  • 财政年份:
    2023
  • 资助金额:
    $ 35.81万
  • 项目类别:
Molecular mechanisms for development of pulmonary invasive mucinous adenocarcinoma
肺浸润性粘液腺癌发生的分子机制
  • 批准号:
    23H02698
  • 财政年份:
    2023
  • 资助金额:
    $ 35.81万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Control mechanisms of lung adenocarcinoma by SGLT2 inhibitors for treating diabetes mellitus.
SGLT2抑制剂治疗糖尿病对肺腺癌的控制机制。
  • 批准号:
    23K08326
  • 财政年份:
    2023
  • 资助金额:
    $ 35.81万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Establishment of histological transformation model from lung small cell carcinoma from adenocarcinoma to explore the therapeutic strategies of small cell lung carcinoma.
建立肺小细胞癌腺癌组织学转化模型,探讨小细胞肺癌的治疗策略。
  • 批准号:
    23K14614
  • 财政年份:
    2023
  • 资助金额:
    $ 35.81万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms of tumor progression controlled by tumor-initiating cells and cancer-associated fibroblasts in pancreatic adenocarcinoma.
阐明胰腺腺癌中肿瘤起始细胞和癌症相关成纤维细胞控制的肿瘤进展机制。
  • 批准号:
    23K15075
  • 财政年份:
    2023
  • 资助金额:
    $ 35.81万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidating the Cellular Origins of lung adenocarcinoma
阐明肺腺癌的细胞起源
  • 批准号:
    10743611
  • 财政年份:
    2023
  • 资助金额:
    $ 35.81万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了